Chloroquine in combination with aptamer-modified nanocomplexes for tumor vessel normalization and efficient erlotinib/Survivin shRNA co-delivery to overcome drug resistance in EGFR-mutated non-small cell lung cancer-Reference-Cited by-同舟云学术

Chloroquine in combination with aptamer-modified nanocomplexes for tumor vessel normalization and efficient erlotinib/Survivin shRNA co-delivery to overcome drug resistance in EGFR-mutated non-small cell lung cancer

Published:2018-08 Issue: Volume:76 Page:257-274
ISSN:1742-7061
Container-title:Acta Biomaterialia
language:en
Short-container-title:Acta Biomaterialia

Author:

Lv Tingting,Li Ziying,Xu Liang,Zhang Yingying,Chen Haijun,Gao Yu

Funder

National Natural Science Foundation of China

Ministry of Science and Technology

Natural Science Foundation of Fujian Province

Publisher

Elsevier BV

Subject

Molecular Biology,Biomedical Engineering,Biochemistry,Biomaterials,General Medicine,Biotechnology

Reference72 articles.

1. The comparison of EGFR-TKI failure modes and subsequent management between exon 19 deletion and exon 21 L858R mutation in advanced non-small-cell lung cancer;Zhang;J. Cancer,2017

2. Quantitative tyrosine phosphoproteomics of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor-treated lung adenocarcinoma cells reveals potential novel biomarkers of therapeutic response;Zhang;Mol. Cell. Proteom. MCP,2017

3. The role of irreversible HER family inhibition in the treatment of patients with non-small cell lung cancer;Kwak;Oncologist,2011

4. BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models;Li;Oncogene,2008

5. Strategies to overcome resistance to tyrosine kinase inhibitors in non-small-cell lung cancer;Santarpia;Expert Rev. Clin. Pharmacol.,2015

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dendrimers as drug delivery systems for oncotherapy: Current status of promising applications;International Journal of Pharmaceutics;2024-09

2. Biologically based strategies for overcoming in vivo barriers with functional nano‐delivery systems;Journal of Biochemical and Molecular Toxicology;2024-08

3. Harnessing nanotechnology for enhanced delivery of erlotinib: a dynamic duo in cancer treatment;Beni-Suef University Journal of Basic and Applied Sciences;2024-07-26

4. Energy metabolism as the hub of advanced non-small cell lung cancer management: a comprehensive view in the framework of predictive, preventive, and personalized medicine;EPMA Journal;2024-04-08

5. Enhancing targeted cancer therapy through multiple drug delivery by silk peptide nanoparticles;Nano Select;2024-02-27